NASDAQ:ATRA | Free Cash Flow | Atara Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.07M
2025-12-31-$5.7M$0.00-$5.7M
2025-03-31-$28.14M$0.00-$28.14M-74.03%
2024-12-31-$24.47M$90,000.00-$24.56M
2024-03-31-$29.61M$127,000.00-$29.74M
2023-12-31-$50.41M$44,000.00-$50.45M
2023-03-31-$38.43M$399,000.00-$38.83M
2022-12-31-$56.88M$37,000.00-$56.92M
2022-03-31-$84.53M$2.61M-$87.13M
2021-12-31-$34.27M$2.47M-$36.74M
2021-03-31-$65.7M$2.2M-$67.9M
2020-12-31-$4.12M$601,000.00-$4.72M
2020-03-31-$67.04M$1.33M-$68.38M
2019-12-31-$58.69M$2.71M-$61.4M
2019-03-31-$70.2M$796,000.00-$71M
2018-12-31-$57.42M$4.17M-$61.59M
2018-03-31-$34.82M$19.81M-$54.63M
2017-12-31-$24.94M$9.7M-$34.64M
2017-03-31-$22.03M$1.21M-$23.24M
2016-12-31-$21.16M$995,000.00-$22.16M
2016-03-31-$12.49M$891,000.00-$13.38M
2015-12-31-$11.39M$271,000.00-$11.66M
2015-03-31-$6.62M$5,000.00-$6.63M
2014-12-31-$4.96M$36,000.00-$4.99M
2014-03-31-$2.92M$1,000.00-$2.92M
2013-12-31-$2.49M$0.00-$2.49M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$50.94M$0.00-$50.94M-155.84%
2024-12-31-$68.72M$246,000.00-$68.96M
2023-12-31-$192.98M$1.22M-$194.2M
2022-12-31-$270.43M$4.19M-$274.62M
2021-12-31-$220.52M$10.58M-$231.1M
2020-12-31-$180.76M$4.51M-$185.27M
2019-12-31-$235.63M$5.73M-$241.36M
2018-12-31-$179.77M$35.93M-$215.7M
2017-12-31-$87.5M$20.23M-$107.73M
2016-12-31-$60.03M$3.02M-$63.05M
2015-12-31-$37.16M$290,000.00-$37.45M
2014-12-31-$16.63M$46,000.00-$16.67M
2013-12-31-$5.97M$3,000.00-$5.97M